Hemostasis during urologic surgery: fibrin sealant compared with absorbable hemostat

In the United States, fibrin sealants have been used to achieve hemostasis for nearly two decades. Although their clinical utility was first demonstrated in cardiac surgery, their effectiveness and safety have since been demonstrated to extend to a wide array of procedures. Fibrin sealants typically...

Full description

Saved in:
Bibliographic Details
Published in:Reviews in urology 2015, Vol.17 (1), p.25-30
Main Authors: Albala, David M, Riebman, Jerome B, Kocharian, Richard, Ilie, Bogdan, Albanese, John, Shen, Jessica, Ovington, Liza, Batiller, Jonathan
Format: Article
Language:English
Subjects:
Original Research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the United States, fibrin sealants have been used to achieve hemostasis for nearly two decades. Although their clinical utility was first demonstrated in cardiac surgery, their effectiveness and safety have since been demonstrated to extend to a wide array of procedures. Fibrin sealants typically contain two components-fibrinogen and thrombin-that are combined and delivered simultaneously to a target bleeding site in order to achieve hemostasis. However, many commercial formulations contain other additional components, such as antifibrinolytic agents, that have been associated with adverse outcomes. This subanalysis compares the safety and effectiveness of a fibrin sealant versus an absorbable hemostat for achieving hemostasis during urologic procedures with mild to moderate bleeding.
ISSN:1523-6161